QLGN Annual Working Capital
-$2.97 M
-$5.18 M-234.25%
31 December 2023
Summary:
As of January 21, 2025, QLGN annual working capital is -$2.97 million, with the most recent change of -$5.18 million (-234.25%) on December 31, 2023. During the last 3 years, it has fallen by -$20.76 million (-116.69%). QLGN annual working capital is now -116.69% below its all-time high of $17.79 million, reached on December 1, 2020.QLGN Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
QLGN Quarterly Working Capital
-$2.14 M
+$2.14 M+49.96%
30 September 2024
Summary:
As of January 21, 2025, QLGN quarterly working capital is -$2.14 million, with the most recent change of +$2.14 million (+49.96%) on September 30, 2024. Over the past year, it has increased by +$1.38 million (+39.21%). QLGN quarterly working capital is now -113.25% below its all-time high of $16.16 million, reached on December 31, 2021.QLGN Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
QLGN Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -234.3% | +39.2% |
| 3 y3 years | -116.7% | -203.1% |
| 5 y5 years | +20.2% | - |
QLGN Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -118.4% | at low | -113.3% | +50.0% |
| 5 y | 5-year | -116.7% | +20.2% | -113.3% | +86.2% |
| alltime | all time | -116.7% | +20.2% | -113.3% | +86.2% |
Qualigen Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -$2.14 M(-50.0%) |
| June 2024 | - | -$4.28 M(+21.5%) |
| Mar 2024 | - | -$3.52 M(+18.6%) |
| Dec 2023 | -$2.97 M(-234.2%) | -$2.97 M(+18.5%) |
| Sept 2023 | - | -$2.51 M(-31.0%) |
| June 2023 | - | -$3.63 M(+414.1%) |
| Mar 2023 | - | -$706.40 K(-131.9%) |
| Dec 2022 | $2.21 M | $2.21 M(-59.9%) |
| Sept 2022 | - | $5.51 M(-31.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2022 | - | $8.06 M(-38.4%) |
| Mar 2022 | - | $13.08 M(-19.1%) |
| Dec 2021 | $16.16 M(-9.2%) | $16.16 M(+56.8%) |
| Sept 2021 | - | $10.31 M(-11.8%) |
| June 2021 | - | $11.69 M(-25.6%) |
| Mar 2021 | - | $15.72 M(-384.2%) |
| Dec 2020 | $17.79 M(-578.3%) | - |
| Sept 2020 | - | -$5.53 M(-64.5%) |
| June 2020 | - | -$15.56 M |
| Mar 2020 | -$3.72 M | - |
FAQ
- What is Qualigen Therapeutics annual working capital?
- What is the all time high annual working capital for Qualigen Therapeutics?
- What is Qualigen Therapeutics annual working capital year-on-year change?
- What is Qualigen Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Qualigen Therapeutics?
- What is Qualigen Therapeutics quarterly working capital year-on-year change?
What is Qualigen Therapeutics annual working capital?
The current annual working capital of QLGN is -$2.97 M
What is the all time high annual working capital for Qualigen Therapeutics?
Qualigen Therapeutics all-time high annual working capital is $17.79 M
What is Qualigen Therapeutics annual working capital year-on-year change?
Over the past year, QLGN annual working capital has changed by -$5.18 M (-234.25%)
What is Qualigen Therapeutics quarterly working capital?
The current quarterly working capital of QLGN is -$2.14 M
What is the all time high quarterly working capital for Qualigen Therapeutics?
Qualigen Therapeutics all-time high quarterly working capital is $16.16 M
What is Qualigen Therapeutics quarterly working capital year-on-year change?
Over the past year, QLGN quarterly working capital has changed by +$1.38 M (+39.21%)